Lupin informs about press release

24 Mar 2022 Evaluate
Lupin has informed that it enclosed press release titled, ‘Lupin Receives Approval from US FDA for Sildenafil for Oral Suspension’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2131.80 10.15 (0.48%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×